Updated Clinical and Correlative Results from the Phase I CRB-402 Study of the BCMA-Targeted CAR T Cell Therapy bb21217 in Patients with Relapsed and Refractory Multiple Myeloma
暂无分享,去创建一个
S. Jagannath | A. Jakubowiak | D. Siegel | N. Munshi | F. Petrocca | N. Raje | J. Kaufman | T. Campbell | Yi Lin | Ashish S. Yeri | J. Rosenblatt | O. Finney | N. Shah | A. Truppel-Hartmann | M. Alsina | J. Berdeja | A. Timm | N. Martin